Author:
Shibabaw Agumas,Gelaw Baye,Ghanem Mostafa,Legall Noah,Schooley Angie M.,Soehnlen Marty K.,Salvador Liliana C.M.,Gebreyes Wondwossen,Wang Shu-Hua,Tessema Belay
Abstract
Abstract
Background
Drug resistant Mycobacterium tuberculosis prevention and care is a major challenge in Ethiopia. The World health organization has designated Ethiopia as one of the 30 high burden multi-drug resistant tuberculosis (MDR-TB) countries. There is limited information regarding genetic diversity and transmission dynamics of MDR-TB in Ethiopia.
Objective
To investigate the molecular epidemiology and transmission dynamics of MDR-TB strains using whole genome sequence (WGS) in the Amhara region.
Methods
Forty-five MDR-TB clinical isolates from Amhara region were collected between 2016 and 2018, and characterized using WGS and 24-loci Mycobacterium Interspersed Repetitive Units Variable Number of Tandem Repeats (MIRU-VNTR) typing. Clusters were defined based on the maximum distance of 12 single nucleotide polymorphisms (SNPs) or alleles as the upper threshold of genomic relatedness. Five or less SNPs or alleles distance or identical 24-loci VNTR typing is denoted as surrogate marker for recent transmission.
Results
Forty-one of the 45 isolates were analyzed by WGS and 44% (18/41) of the isolates were distributed into 4 clusters. Of the 41 MDR-TB isolates, 58.5% were classified as lineage 4, 36.5% lineage 3 and 5% lineage 1. Overall, TUR genotype (54%) was the predominant in MDR-TB strains. 41% (17/41) of the isolates were clustered into four WGS groups and the remaining isolates were unique strains. The predominant cluster (Cluster 1) was composed of nine isolates belonging to lineage 4 and of these, four isolates were in the recent transmission links.
Conclusions
Majority of MDR-TB strain cluster and predominance of TUR lineage in the Amhara region give rise to concerns for possible ongoing transmission. Efforts to strengthen TB laboratory to advance diagnosis, intensified active case finding, and expanded contact tracing activities are needed in order to improve rapid diagnosis and initiate early treatment. This would lead to the interruption of the transmission chain and stop the spread of MDR-TB in the Amhara region.
Publisher
Springer Science and Business Media LLC
Reference63 articles.
1. Jabbar A, Phelan JE, de Sessions PF, Khan T, Rahman H, Khan SN, et al. Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan. Sci Rep. 2019;9:14996. https://doi.org/10.1038/s41598-019-51562-6.
2. World Health Organization. Global tuberculosis report 2021. 2021.
3. World Health Organization. WHO announces updated definitions of extensively drug-resistant tuberculosis. 2021:https://www.who.int/news/item/27-01-2021-who-announces-updated-definitions-of-extensively-drug-resistant-tuberculosis. Access on August, 20, 2022.
4. Menzies D, Benedetti A, Paydar A, Royce S, Pai M, Burman W, et al. Standardized treatment of active tuberculosis in patients with previous treatment and/or with monoresistance to isoniazid: a systematic review and meta-analysis. PLoS Med. 2009;6:e1000150.
5. da Garrido S, Bührer-Sékula M, Souza S, de Oliveira AB, Antunes GP, Mendes A. Multidrug-resistant tuberculosis in the Amazonas State, Brazil, 2000–2011. Int J Tuberc Lung Dis. 2015;19:531–6.